Natco inks deal with Mabxience to manufacture mAb drugs
Three of the four products including Trastuzumab, Bevacizumab, Rituximab belong to the oncology segment, while Etanercept is used to treat auto-immune disease. As per the terms of the
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.